Skip to main content
YS Biopharma Co., Ltd. (YS)
NASDAQ: YS · IEX Real-Time Price · USD
0.725
-0.130 (-15.16%)
At close: Apr 19, 2024, 3:59 PM
0.768
+0.043 (5.90%)
After-hours: Apr 19, 2024, 7:27 PM EDT

YS Biopharma Co. Stock Forecast

YS's stock price has decreased by -59.46% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for YS Biopharma Co. stock has a target of 5.25, which predicts an increase of 623.74% from the current stock price of 0.73.

Analyst Consensus: Buy
Target Low Average Median High
Price $5.25 $5.25 $5.25 $5.25
Change +623.74% +623.74% +623.74% +623.74%
* Price targets were last updated on Nov 13, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for YS is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Mar '24Apr '24
Strong Buy 00
Buy 11
Hold 00
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Gregory Aurand
Noble Capital Markets
 Noble Capital Markets
Buy
Initiates
$5.25
 Buy Initiates $5.25 +623.74% Nov 13, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
88.63M
from 687.20M
Decreased by -87.10%
Revenue Next Year
598.47M
from 88.63M
Increased by 575.23%
EPS This Year
-0.34
from -1.56
EPS Next Year
-2.55
from -0.34
Year 202020212022202320232024202420252025202620262027202720282028
Revenue
257.02M502.95M687.20M88.63M598.47M112.79M844.69M197.57M1.43B1.83B254.75M2.01B280.01M2.46B343.84M
Revenue Growth
-95.69%36.63%-87.10%575.23%-81.15%648.91%-76.61%624.30%27.60%-86.05%687.83%-86.05%779.97%-86.05%
EPS
-3.10-1.71-1.56-0.34-2.55-0.11-1.120.041.04------
EPS Growth
--------2,729.13%------
No. Analysts ---454544444444
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202320242025202620272028
High 611.0M 905.5M 1.5B 259.7M 285.5M 350.5M
Avg 598.5M 844.7M 1.4B 254.8M 280.0M 343.8M
Low 568.5M 762.2M 1.3B 242.4M 266.4M 327.2M

Revenue Growth

Revenue Growth 202320242025202620272028
High
-11.1%
51.3%
80.8%
-81.9%
12.1%
25.2%
Avg
-12.9%
41.1%
69.4%
-82.2%
9.9%
22.8%
Low
-17.3%
27.4%
53.7%
-83.1%
4.6%
16.8%

EPS Forecast

EPS 202320242025
High -1.85 -1.13 1.06
Avg -2.55 -1.12 1.04
Low -3.13 -1.07 0.99

EPS Growth

EPS Growth 202320242025
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.